Newsfeeds - Spark Newswire

1 minute read

WeTrade Shares Soar On Collaboration Over Exclusive COVID-19 Omicron Disinfectant

Today, 7:23 PM

Software-as-a-services (SAAS) and cloud intelligent systems provider WeTrade Group Inc (NASDAQ:WETG) is in an advanced discussion with Zhixun Biotechnology Limited to launch an in-depth…

BVNKF

1 minute read

As The Only Monkeypox Maker Struggles, This Small Cap Plans To Develop Novel Shot

By Vandana Singh

Today, 7:23 PM

Blue Water Vaccines Inc (NASDAQ: BWV)

BVNKF

1 minute read

WeTrade’s Monkeypox Testing Kits May Go Global. Why A New Agreement Is Sending Shares Soaring Double Digits?

By Anusuya Lahiri

Today, 7:23 PM

WeTrade Group Inc (NASDAQ: WETG) collaborated with MobiLab Medical Innovatives to launch a globally unparalleled and one-of-a-kind Monkeypox Virus testing kit with…

EBS

1 minute read

Emergent BioSolutions Posts Q2 Loss On Lower Sales, Q3 Forecasts Below Consensus

By Vandana Singh

Today, 7:23 PM

Emergent BioSolutions Inc’s (NYSE: EBS) Q2 sales fell 39% Y/Y to $242.7 million, missing the consensus of $270.94 million. Revenues from…

AZN

5 minute read

Why Applied DNA Sciences Is Trading Higher By 166%, Here Are 75 Stocks Moving In Tuesday’s Mid-Day Session

By Lisa Levin

Today, 7:23 PM

Gainers AMTD IDEA Group (NYSE: AMTD) shares jumped 284% to $8.00 after jumping 18% on Monday. The company owns 90%+ of AMTD Digital.

ACON

2 minute read

Avis Budget, Zebra Technologies And Some Other Big Stocks Moving Lower On Tuesday

By Lisa Levin

Today, 7:23 PM

FAT Brands Inc. (NASDAQ: FATBB) fell 30% to $10.50. The company recently posted a Q2 net loss of $8.2 million or $0.50 per share.

ABR

1 minute read

Earnings

Recap: Emergent BioSolutions Q2 Earnings

By Benzinga Insights

Today, 7:23 PM

Emergent BioSolutions (NYSE:EBS) reported its Q2 earnings results on Monday, August 1, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

EBS

1 minute read

Emergent BioSolutions Q2 EPS $(0.86) Misses $0.37 Estimate, Sales $242.70M Miss $270.94M Estimate

By Benzinga Newsdesk

Today, 7:23 PM

Emergent BioSolutions (NYSE:EBS) reported quarterly losses of $(0.86) per share which missed the analyst consensus estimate of $0.37 by 332.43 percent. This is a 360.61 percent decrease over earnings of $0.33 per share

EBS

7 minute read

Earnings Scheduled For August 1, 2022

By Benzinga Insights

Today, 7:23 PM

Companies Reporting Before The Bell • Bon Natural Life (NASDAQ:BON) is projected to report earnings for its first quarter.

ACT

1 minute read

Earnings

Earnings Outlook For Emergent BioSolutions

By Benzinga Insights

Today, 7:23 PM

Emergent BioSolutions (NYSE:EBS) is set to give its latest quarterly earnings report on Monday, 2022-08-01. Here's what investors need to know before the announcement. Analysts estimate that Emergent BioSolutions will report an earnings per share (EPS) of $0.37.

EBS